NEBIZIDE 5 MG / 25 MG FILM-COATED TABLETS
Active substance(s): HYDROCHLOROTHIAZIDE / NEBIVOLOL HYDROCHLORIDE / HYDROCHLOROTHIAZIDE / NEBIVOLOL HYDROCHLORIDE / HYDROCHLOROTHIAZIDE / NEBIVOLOL HYDROCHLORIDE
NEBIZIDE 5 mg / 25 mg film-coated tablets
Nebivolol / Hydrochlorothiazide
Read all of this leaflet carefully before you start using this medicine because it contains important
information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their
signs of illness are the same as yours.
- If you get any side effects talk to your doctor or pharmacist or nurse. This includes any possible side effects not
listed in this leaflet. See section 4.
What is in this leaflet:
1. What Nebizide is and what it is used for
2. What you need to know before you take Nebizide
3. How to take Nebizide
4. Possible side effects
5. How to store Nebizide
6. Contents of the pack and other information
1. What Nebizide is and what it is used for
Nebizide contains nebivolol and hydrochlorothiazide as the active ingredients.
Nebivolol is a cardiovascular drug belonging to the group of selective beta-blocking agents (i.e. with a
selective action on the cardiovascular system). It prevents increased heart rate and controls heart pumping
strength. It also widens blood vessels, which helps to lower your blood pressure.
Hydrochlorothiazide is a diuretic, that acts by increasing the amount of urine you produce.
Nebizide is a one-tablet combination of nebivolol and hydrochlorothiazide and is used for the treatment of raised
blood pressure (hypertension). It is used instead of the two separate products for those patients who are already
taking them together.
2. What you need to know before you take Nebizide
Do not take Nebizide
if you are allergic to nebivolol or to hydrochlorothiazide or to any of the other ingredients of this medicine
(listed in section 6).
if you are allergic (hypersensitive) to other sulphonamide-derived substances (like hydrochlorothiazide, which
is a sulphonamide-derived drug)
if you have one or more of the following disorders:
very slow heartbeat (less than 60 beats per minute)
certain other serious heart rhythm problems (e.g. sick sinus syndrome, sino-atrial block, 2nd and 3rd degree
heart failure, which has just occurred or which has recently become worse, or you are receiving treatment
for circulatory shock due to acute heart failure by intravenous drip feed to help your heart work
low blood pressure
serious circulation problems in the arms or legs
untreated phaeochromocytoma, a tumour located on top of the kidneys (in the adrenal glands)
severe kidney problems, complete absence of urine (anuria)
a metabolic disorder (metabolic acidosis), e.g., diabetic ketoacidosis.
asthma or wheezing (now or in the past)
liver function disorder
high blood calcium, low blood potassium, low blood sodium levels that are persistent and resistant to
high uric acid levels with gout symptoms
Warnings and precautions
Talk to your doctor or pharmacist before taking Nebizide
Inform your doctor if you have or develop one of the following problems:
a type of chest pain due to spontaneously occurring heart cramp, called Prinzmetal angina
1st degree heart block (a kind of mild heart conduction impairment that affects heart rhythm)
abnormally slow heartbeat
untreated chronic heart failure
lupus erythematosus (a disorder of the immune system, i.e. your body’s defence system)
psoriasis (a skin disease characterised by scaly pink patches) or if you have ever had psoriasis
overactive thyroid gland: this medicine may mask the signs of an abnormally fast heart rate due to this
poor circulation in the arms or legs, e.g. Raynaud’s disease or syndrome, cramp-like pains when walking
allergy: this medicine may intensify your reaction to pollen or other substances you are allergic to
prolonged breathing problems
diabetes: this medicine could conceal the warning signs of a low sugar level (e.g. palpitations, fast heartbeat);
your doctor will also tell you to check your blood sugar more often while taking Nebizide, as the dose of your
antidiabetic drugs may need to be adjusted
kidney problems: your doctor will check your kidney function to make sure it does not get worse. If you have
serious kidney problems do not take Nebizide (see section ‘Do not take Nebizide’)
if you tend to have low blood potassium, and especially if you suffer from prolonged QT syndrome (a kind of
ECG abnormality) or you are taking digitalis (to help your heart pump); you are more likely to have low
blood potassium if you suffer from liver cirrhosis, or have had too rapid a loss of water due to a strong
diuretic treatment, of if your intake of potassium with food and drinks is inadequate
if you have to have surgery, always inform your anaesthetist that you are on Nebizide before being
Nebizide may increase blood fat levels and uric acid. It may affect the levels of certain chemicals in your
blood, called electrolytes: your doctor will check them from time to time via a blood test.
The hydrochlorothiazide in Nebizide may cause your skin to be oversensitive to sunlight or artificial UV light.
Stop taking Nebizide and tell your doctor if you get a rash, itchy spots or sensitive skin during treatment (see
also Section 4).
Anti-dope test: Nebizide could cause a positive anti-dope test.
Children and adolescents
Because of the lack of data on the use of the product in children and adolescents, Nebizide is not recommended for
use in them.
Other medicines and Nebizide
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Always tell your doctor if you are using or receiving any of the following medicines in addition to Nebizide:
Medicines that, as well as Nebizide, may influence the blood pressure and/or heart function:
Medicines for controlling blood pressure or medicines for heart problems (such as amiodarone, amlodipine,
cibenzoline, clonidine, digoxin, diltiazem, disopyramide, dofetilide, felodipine, flecainide, guanfacine,
hydroquinidine, ibutilide, lacidipine, lidocaine, mexiletine, methyldopa, moxonidine, nicardipine,
nifedipine, nimodipine, nitrendipine, propafenone, quinidine, rilmenidine, sotalol, verapamil)
Sedatives and therapies for psychosis (a mental illness) e.g. amisulpiride, barbiturates (also used for
epilepsy), chlorpromazine, cyamemazine, droperidol, haloperidol, levomepromazine, narcotic drugs,
phenothiazine (also used for vomiting and nausea), pimozide, sulpiride, sultopride, thioridazine, tiapride
Medicines for depression e.g. amitriptyline, fluoxetine, paroxetine
Medicines used for anaesthesia during an operation
Medicines for asthma, blocked nose or certain eye disorders such as glaucoma (increased pressure in the
eye) or dilation (widening) of the pupil
Baclofen (an antispasmodic drug)
Amifostine (a protective medicine used during cancer treatment)
Medicines whose effect or toxicity may be increased by Nebizide:
Lithium, used as a mood stabilizer
Cisapride (used for digestive problems)
Bepridil (used for angina)
Diphemanil (used for excessive sweating)
Medicines used for infections: erythromycin given by infusion or injection, pentamidine and sparfloxacin,
amphotericin and penicillin G sodium, halofantrine (used for malaria)
Vincamine (used for brain circulation problems)
Mizolastine and terfenadine (used for allergy
Diuretics and laxatives
Medicines used to treat acute inflammation: steroids (e.g cortisone and prednisone), ACTH
(adrenocorticotropic hormone) and medicines derived from salicylic acid (e.g. acetylsalicylic acid/aspirin
and other salicylates)
Carbenoxolone (used for heartburn and stomach ulcer)
Calcium salts, used as supplements for bone health
Medicines used to relax muscles (e.g. tubocurarine)
Diaxozide, used to treat low blood sugar and high blood pressure
Amantadine, an antiviral medicine
Cyclosporine, used to suppress the body’s immune response
Iodinated contrast media, used for contrast in X-ray scans
Anti-cancer medicines (e.g. cyclophosphamide, fluorouracil, methotrexate)
Medicines whose effect may be decreased by Nebizide:
Blood sugar-lowering medicines (insulin and oral antidiabetic drugs, metformin)
Medicines for gout (e.g. allopurinol, probenecid and sulfinpyrazone)
Medicines like noradrenalin, used to treat low blood pressure or slow heart rate
Medicines for pain and inflammation (non-steroidal anti-inflammatory drugs), as they may reduce the blood
pressure lowering effect of Nebizide
Medicines for treating excessive stomach acid or ulcers (antacid), e.g. cimitedine: you should take Nebizide
during a meal and the antacid between meals.
Nebizide with alcohol
Take care when drinking alcohol while you are taking Nebizide, as you may feel faint or dizzy. If this happens to
you, do not drink any alcohol, including wine, beer or alcopops.
Pregnancy and breast-feeding
You must tell your doctor if you are pregnant or if you think that you are. Usually, your doctor will advise you to
take another medicine instead of Nebizide, as Nebizide is not recommended during pregnancy. This is because the
active ingredient hydrochlorothiazide crosses the placenta. The use of Nebizide during pregnancy may cause
potentially harmful foetal and neonatal effects.
Tell your doctor if you are breast-feeding or about to start breast-feeding. Nebizide is not recommended for
mothers who are breast-feeding.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or
pharmacist for advice before taking this medicine.
Driving and using machines
This medicine may cause dizziness or fatigue. If affected, do not drive or operate machinery.
Nebizide contains lactose
This product contains lactose. If you have been told by your doctor that you have an intolerance to some sugars,
contact your doctor before taking this medicine.
3. How to take Nebizide
Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.
Take 1 tablet a day with some water, preferably at the same time of day.
Nebizide may be taken before, during or after a meal, but you can take it independently of meals.
Use in children and adolescents
Do not give Nebizide to children or adolescents.
If you take more Nebizide than you should
If you accidentally take an overdose of this medicine, tell your doctor or pharmacist immediately. The most
frequent symptoms and signs of overdose are very slow heart beat (bradycardia), low blood pressure with possible
fainting, breathlessness such as in asthma, acute heart failure, excessive urination with consequent dehydration,
nausea and somnolence, muscle spasms, heart rhythm disturbances (especially if you are also taking digitalis or
medicines for heart rhythm problems).
If you forget to take Nebizide
If you forget a dose of Nebizide, but remember a little later on that you should have taken it, take that day’s dose as
usual. However, if a long delay has occurred (e.g. several hours), so that the next due dose is near, skip the
forgotten dose and take the next, scheduled, normal dose at the usual time. Do not take a double dose. Repeated
skipping, however, should be avoided.
If you stop taking Nebizide
Always consult your doctor before stopping Nebizide treatment.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been reported with nebivolol:
Common side effects (may affect up to 1 in 10 people):
- an unusual burning, pricking, tickling, or tingling sensation
- shortness of breath
- swollen hands or feet.
Uncommon side effects (may affect up to 1 in 100 people):
- slow heartbeat or other heart complaints
- low blood pressure
- cramp-like leg pains on walking
feelings of depression
digestive difficulties, gas in stomach or bowel, vomiting
skin rash, itchiness
breathlessness such as in asthma, due to sudden cramps in the muscles around the airways (bronchospasm)
Very rare side effects (may affect up to 1 in 10,000 people):
- worsening of psoriasis (a skin disease characterised by scaly pink patches).
The following side effects have been reported only in some isolated cases:
- whole-body allergic reactions, with generalised skin eruption (hypersensitivity reactions);
- rapid-onset swelling, especially around the lips, eyes, or of the tongue with possible sudden difficulty breathing
- kind of skin rash notable for pale red, raised, itchy bumps of allergic or non allergic causes (urticaria).
The following side effects have been reported with hydrochlorothiazide:
- whole-body allergic reaction (anaphylactic reaction)
Heart and circulation
- heart rhythm disturbances, palpitations
- changes in the electrocardiogram
- sudden fainting when standing upright, formation of blood clots in veins (thrombosis) and embolism,
circulatory collapse (shock)
- changes in the number of blood cells, such as: decreased white blood cells, decreased blood platelets, decreased
red blood cells; impaired production of new blood cells by the bone marrow
- altered levels of body fluids (dehydration) and blood chemicals, in particular decreased potassium, decreased
sodium, decreased magnesium, decreased chlorine and increased calcium
- increased uric acid levels, gout, increased blood glucose, diabetes, metabolic alkalosis (a disorder of
metabolism), increased blood cholesterol and/or triglycerides
Stomach and gut
- lack of appetite, dry mouth, nausea, vomiting, stomach discomfort, abdominal pain, diarrhoea, fewer bowel
movements (constipation), absence of bowel movements (ileus paralytic), flatulence
- inflammation of the glands that produce saliva, inflammation of the pancreas, increased blood amylase level (a
- yellowing of the skin (jaundice), inflammation of the gall bladder
- respiratory distress, lung inflammation (pneumonitis), formation of fibrous tissue in the lungs (interstitial lung
disease), fluid accumulation in the lung (pulmonary oedema)
- vertigo (spinning sensation)
- convulsions, depressed level of consciousness, coma, headache, dizziness
- apathy, confusional state, depression, nervousness, restlessness, sleep disturbances
- unusual burning, pricking, tickling, or tingling skin sensations
- muscle weakness (paresis)
Skin and hair
- itchiness, purple spots/blotches on the skin (purpura), hives (urticaria), increased sensitivity of your skin to
sunlight, rash, facial rash and/or patchy redness that can cause scarring (cutaneous lupus erythematosus),
inflammation of blood vessels with consequent death of tissue (vasculitis necrotising), peeling, redness,
loosening, and blistering of the skin (toxic epidermal necrolysis)
Eyes and ears
- yellow vision, blurred vision, worsening of myopia, decreased tear production
Joint and muscles
- muscle spasm, muscle pain
- kidney dysfunction, acute kidney failure (reduced urine production and build-up of fluid and wastes in your
body), inflammation of the connective tissue within the kidneys (interstitial nephritis), sugar in the urine.
- Erection disturbances
- General weakness, tiredness, fever, thirst
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not
listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme. Website:
www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of
5. How to store Nebilet Plus
Keep this medicine out of the sight and reach of children.
This medicinal product does not require any special storage condition.
Do not use this medicine after the expiry date which is stated on the box and on the blister pack after ‘EXP’. The
expiry date refers to the last day of that month.
Do not throw away any medicine via wastewater or household waste.
Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the
Contents of the pack and other information
What Nebilet Plus contains
- The active substances are nebivolol and hydrochlorothiazide. Each tablet contains 5 mg nebivolol (as nebivolol
hydrochloride) 2.5 mg of d-nebivolol and 2.5 mg of l-nebivolol) and 25 mg of hydrochlorothiazide
The other ingredients are:
tablet core: lactose monohydrate, polysorbate 80 (E433), hypromellose (E464), maize starch,
croscarmellose sodium (E468), cellulose microcrystalline (E460), silica colloidal anhydrous (E551),
magnesium stearate (E572)
coating: macrogol 40 stearate Type I, titanium dioxide (E171), carmines (carminic acid aluminium lake,
E120), hypromellose (E464), cellulose microcrystalline (E460).
What Nebizide looks like and contents of the pack
Nebizide is available as almost violet, round, slight biconvex film-coated tablets with “5/25” embossed on one side
in packs of 7, 14, 28, 30, 56, 90 film-coated tablets.
Tablets are provided in blisters (PP/COC/PP/Aluminium blister).
(Not all pack sizes may be marketed)
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Menarini International Operations Luxembourg S.A.
1, Avenue de la Gare L-1611 Luxembourg
Glienicker Weg 125, 12489 Berlin, Germany
Menarini – Von Heyden GmbH
Leipziger Strasse 7-13, 01097 – Dresden, Germany
A. Menarini Manufacturing Logistics and Services S.r.l.
Via Sette Santi 3, 50131 Florence, Italy
This medicinal product is authorised in the member states of the EEA under the following names
Austria: Nomexor plus HCT
Iceland: Nebilet Comp
Ireland: Nebilet Plus
Portugal: Hypoloc Plus
Spain: Silostar Plus
Sweden: Nebilet Comp
The Netherlands: Hyporetic
United Kingdom: Nebizide
This leaflet was last revised in 01/2015.
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.